The application of these MRI visual rating scales for the detection of prodromal AD and AD in Latin America, where limited access to CSF and brain PET using amyloid and tau exists may aid the neurologist, geriatrician, or radiologist in the community in identifying patients with these conditions. The gene discussed is MAPT; the disease is Alzheimer disease.